(BAMNB) Koninklijke BAM Groep - Overview
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0000337319
Stock: Construction, Infrastructure, Property, Buildings, Maintenance
Total Rating 59
Risk 69
Buy Signal -0.95
| Risk 5d forecast | |
|---|---|
| Volatility | 37.0% |
| Relative Tail Risk | -11.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.62 |
| Alpha | 66.57 |
| Character TTM | |
|---|---|
| Beta | 0.444 |
| Beta Downside | -0.008 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.67% |
| CAGR/Max DD | 3.65 |
Description: BAMNB Koninklijke BAM Groep March 05, 2026
Koninklijke BAM Groep nv operates in construction, civil engineering, and public-private partnerships (PPP) globally. The construction sector is cyclical, influenced by economic growth and interest rates.
The company builds and maintains diverse infrastructure, including roads, railways, and bridges. Infrastructure projects often involve long development cycles and significant capital investment.
BAM also constructs residential properties, such as low-rise and mid-rise buildings, and manufactures wooden homes. The residential construction market is sensitive to housing demand and mortgage rates.
Additionally, the company designs, builds, and maintains commercial buildings, hospitals, and industrial complexes. PPPs represent a business model where private companies collaborate with public entities for project delivery.
Further research on ValueRay can provide more in-depth financial and operational data for BAMNB.
Headlines to watch out for
- Infrastructure project pipeline drives civil engineering revenue
- Residential construction demand impacts building division
- Public-private partnership project awards secure future earnings
- Raw material cost fluctuations pressure profit margins
- Government infrastructure spending policies influence project volume
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 293.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 12.98 > 1.0 |
| NWC/Revenue: -0.40% < 20% (prev -0.97%; Δ 0.57% < -1%) |
| CFO/TA 0.15 > 3% & CFO 601.4m > Net Income 293.2m |
| Net Debt (-311.3m) to EBITDA (630.0m): -0.49 < 3 |
| Current Ratio: 0.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (260.7m) vs 12m ago -5.26% < -2% |
| Gross Margin: 16.59% > 18% (prev 0.14%; Δ 1.65k% > 0.5%) |
| Asset Turnover: 334.3% > 50% (prev 236.8%; Δ 97.51% > 0%) |
| Interest Coverage Ratio: 13.12 > 6 (EBITDA TTM 630.0m / Interest Expense TTM 26.3m) |
Altman Z'' 0.97
| A: -0.01 (Total Current Assets 2.73b - Total Current Liabilities 2.78b) / Total Assets 4.10b |
| B: 0.05 (Retained Earnings 209.7m / Total Assets 4.10b) |
| C: 0.09 (EBIT TTM 344.4m / Avg Total Assets 4.04b) |
| D: 0.30 (Book Value of Equity 958.0m / Total Liabilities 3.14b) |
| Altman-Z'' Score: 0.97 = BB |
Beneish M -3.24
| DSRI: 0.75 (Receivables 1.31b/1.21b, Revenue 13.49b/9.41b) |
| GMI: 0.82 (GM 16.59% / 13.58%) |
| AQI: 0.86 (AQ_t 0.20 / AQ_t-1 0.24) |
| SGI: 1.43 (Revenue 13.49b / 9.41b) |
| TATA: -0.08 (NI 293.2m - CFO 601.4m) / TA 4.10b) |
| Beneish M-Score: -3.24 (Cap -4..+1) = AA |
What is the price of BAMNB shares?
As of March 20, 2026, the stock is trading at EUR 8.95 with a total of 856,955 shares traded.
Over the past week, the price has changed by -0.78%, over one month by -9.05%, over three months by -3.61% and over the past year by +75.45%.
Over the past week, the price has changed by -0.78%, over one month by -9.05%, over three months by -3.61% and over the past year by +75.45%.
Is BAMNB a buy, sell or hold?
Koninklijke BAM Groep has no consensus analysts rating.
What are the forecasts/targets for the BAMNB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.5 | 5.9% |
| Analysts Target Price | - | - |
BAMNB Fundamental Data Overview March 19, 2026
Market Cap USD = 2.75b (2.40b EUR * 1.1464 EUR.USD)
P/E Trailing = 11.5313
P/E Forward = 10.6838
P/S = 0.3403
P/B = 2.4391
P/EG = 11.1111
Revenue TTM = 13.49b EUR
EBIT TTM = 344.4m EUR
EBITDA TTM = 630.0m EUR
Long Term Debt = 56.3m EUR (from longTermDebt, last quarter)
Short Term Debt = 135.0m EUR (from shortTermDebt, last quarter)
Debt = 572.1m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -311.3m EUR (from netDebt column, last quarter)
Enterprise Value = 2.08b EUR (2.40b + Debt 572.1m - CCE 883.4m)
Interest Coverage Ratio = 13.12 (Ebit TTM 344.4m / Interest Expense TTM 26.3m)
EV/FCF = 3.67x (Enterprise Value 2.08b / FCF TTM 567.7m)
FCF Yield = 27.23% (FCF TTM 567.7m / Enterprise Value 2.08b)
FCF Margin = 4.21% (FCF TTM 567.7m / Revenue TTM 13.49b)
Net Margin = 2.17% (Net Income TTM 293.2m / Revenue TTM 13.49b)
Gross Margin = 16.59% ((Revenue TTM 13.49b - Cost of Revenue TTM 11.26b) / Revenue TTM)
Gross Margin QoQ = 6.37% (prev 27.87%)
Tobins Q-Ratio = 0.51 (Enterprise Value 2.08b / Total Assets 4.10b)
Interest Expense / Debt = 1.54% (Interest Expense 8.80m / Debt 572.1m)
Taxrate = 19.43% (26.4m / 135.9m)
NOPAT = 277.5m (EBIT 344.4m * (1 - 19.43%))
Current Ratio = 0.98 (Total Current Assets 2.73b / Total Current Liabilities 2.78b)
Debt / Equity = 0.60 (Debt 572.1m / totalStockholderEquity, last quarter 958.0m)
Debt / EBITDA = -0.49 (Net Debt -311.3m / EBITDA 630.0m)
Debt / FCF = -0.55 (Net Debt -311.3m / FCF TTM 567.7m)
Total Stockholder Equity = 920.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.26% (Net Income 293.2m / Total Assets 4.10b)
RoE = 31.84% (Net Income TTM 293.2m / Total Stockholder Equity 920.9m)
RoCE = 35.25% (EBIT 344.4m / Capital Employed (Equity 920.9m + L.T.Debt 56.3m))
RoIC = 27.80% (NOPAT 277.5m / Invested Capital 998.4m)
WACC = 6.33% (E(2.40b)/V(2.97b) * Re(7.55%) + D(572.1m)/V(2.97b) * Rd(1.54%) * (1-Tc(0.19)))
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -2.67%
[DCF] Terminal Value 78.47% ; FCFF base≈354.3m ; Y1≈232.6m ; Y5≈106.1m
[DCF] Fair Price = 12.80 (EV 2.98b - Net Debt -311.3m = Equity 3.29b / Shares 257.2m; r=6.33% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 0.12 | EPS CAGR: -22.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: 43.40 | Revenue CAGR: 3.87% | SUE: 0.30 | # QB: 0
EPS current Year (2026-12-31): EPS=0.95 | Chg7d=-0.013 | Chg30d=-0.013 | Revisions Net=+1 | Growth EPS=+14.4% | Growth Revenue=+5.2%
EPS next Year (2027-12-31): EPS=1.01 | Chg7d=-0.001 | Chg30d=-0.001 | Revisions Net=+1 | Growth EPS=+7.1% | Growth Revenue=-0.6%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -0.7% (Discount Rate 7.9% - Earnings Yield 8.7%)
[Growth] Growth Spread = +0.2% (Analyst -0.6% - Implied -0.7%)
P/E Trailing = 11.5313
P/E Forward = 10.6838
P/S = 0.3403
P/B = 2.4391
P/EG = 11.1111
Revenue TTM = 13.49b EUR
EBIT TTM = 344.4m EUR
EBITDA TTM = 630.0m EUR
Long Term Debt = 56.3m EUR (from longTermDebt, last quarter)
Short Term Debt = 135.0m EUR (from shortTermDebt, last quarter)
Debt = 572.1m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -311.3m EUR (from netDebt column, last quarter)
Enterprise Value = 2.08b EUR (2.40b + Debt 572.1m - CCE 883.4m)
Interest Coverage Ratio = 13.12 (Ebit TTM 344.4m / Interest Expense TTM 26.3m)
EV/FCF = 3.67x (Enterprise Value 2.08b / FCF TTM 567.7m)
FCF Yield = 27.23% (FCF TTM 567.7m / Enterprise Value 2.08b)
FCF Margin = 4.21% (FCF TTM 567.7m / Revenue TTM 13.49b)
Net Margin = 2.17% (Net Income TTM 293.2m / Revenue TTM 13.49b)
Gross Margin = 16.59% ((Revenue TTM 13.49b - Cost of Revenue TTM 11.26b) / Revenue TTM)
Gross Margin QoQ = 6.37% (prev 27.87%)
Tobins Q-Ratio = 0.51 (Enterprise Value 2.08b / Total Assets 4.10b)
Interest Expense / Debt = 1.54% (Interest Expense 8.80m / Debt 572.1m)
Taxrate = 19.43% (26.4m / 135.9m)
NOPAT = 277.5m (EBIT 344.4m * (1 - 19.43%))
Current Ratio = 0.98 (Total Current Assets 2.73b / Total Current Liabilities 2.78b)
Debt / Equity = 0.60 (Debt 572.1m / totalStockholderEquity, last quarter 958.0m)
Debt / EBITDA = -0.49 (Net Debt -311.3m / EBITDA 630.0m)
Debt / FCF = -0.55 (Net Debt -311.3m / FCF TTM 567.7m)
Total Stockholder Equity = 920.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.26% (Net Income 293.2m / Total Assets 4.10b)
RoE = 31.84% (Net Income TTM 293.2m / Total Stockholder Equity 920.9m)
RoCE = 35.25% (EBIT 344.4m / Capital Employed (Equity 920.9m + L.T.Debt 56.3m))
RoIC = 27.80% (NOPAT 277.5m / Invested Capital 998.4m)
WACC = 6.33% (E(2.40b)/V(2.97b) * Re(7.55%) + D(572.1m)/V(2.97b) * Rd(1.54%) * (1-Tc(0.19)))
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -2.67%
[DCF] Terminal Value 78.47% ; FCFF base≈354.3m ; Y1≈232.6m ; Y5≈106.1m
[DCF] Fair Price = 12.80 (EV 2.98b - Net Debt -311.3m = Equity 3.29b / Shares 257.2m; r=6.33% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 0.12 | EPS CAGR: -22.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: 43.40 | Revenue CAGR: 3.87% | SUE: 0.30 | # QB: 0
EPS current Year (2026-12-31): EPS=0.95 | Chg7d=-0.013 | Chg30d=-0.013 | Revisions Net=+1 | Growth EPS=+14.4% | Growth Revenue=+5.2%
EPS next Year (2027-12-31): EPS=1.01 | Chg7d=-0.001 | Chg30d=-0.001 | Revisions Net=+1 | Growth EPS=+7.1% | Growth Revenue=-0.6%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -0.7% (Discount Rate 7.9% - Earnings Yield 8.7%)
[Growth] Growth Spread = +0.2% (Analyst -0.6% - Implied -0.7%)